Phebra
Products by Category  
 
 
 
Our Business Our Products How to order Contact Us
  News  

  • BREAKING NEWS: Phebra, new name and era for critical medicines company:
    27 November, 2007. More
  • The Inaugural Eutick Memorial Still Life Award:
    October, 2007. More
  • Phebra acquires critical sterile products from Mayne Pharma:
    20 March, 2007. More
  • Sodium fluorescein announcement:
    24 October, 2006. More
More News


A dynamic and innovative Australian pharmaceutical company supplying critical medicinal needs.

Phebra specialises in the manufacture and distribution of critically needed products  with a primary focus on supply to hospitals.

Our product range covers the therapeutic areas of pain management, cardiovascular management, paediatrics, antidotes, neurology, endocrinology, in vivo diagnostic dyes and markers and vitamins, ophthalmology, anti-infectives and electrolyte replacement.
 
At Phebra, our inspiration and commitment comes from providing life-enhancing medicines that improve the quality of patient’s lives. We pride ourselves in providing quality pharmaceuticals to meet the requirements of a niche market, knowing that we are improving people’s health. 


  Product Feature  
Charcotrace
CharcotraceInjectable suspension of fine charcoal particles as an aid in stereotactic or ultrasonic localization of small impalpable lesions of the breast for later surgical excision.

Click here for a list of Charcotrace-specific studies and publications.


  Phone: +61 (0)2 9420 9199   Home    News   Links    Print    Disclaimer   Site Map    Login    Site by viva!